Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

EuroIntervention 2018;14:e318-e324 published online ahead of print May 2018 published online e-edition June 2018. DOI: 10.4244/EIJ-D-18-00346

Simon Walsh
Simon J. Walsh1*, MD; Colm G. Hanratty1, MD; Stuart Watkins2, MD; Keith G. Oldroyd2, MD; Niall T. Mulvihill3, MD; Mark Hensey3, MD; Alex Chase4, MD; Dave Smith4, MD; Nick Cruden5, MD; James C. Spratt5,6, MD; Darren Mylotte7, MD; Tom Johnson8, MD; Jonathan Hill9, MD; Hafiz M. Hussein10, MB BCh; Kris Bogaerts11, PhD; Marie-Claude Morice12, MD; David P. Foley10, MD
1. Belfast Health & Social Care Trust, Belfast, Northern Ireland, United Kingdom; 2. Golden Jubilee National Hospital, Glasgow, Scotland, United Kingdom; 3. St. Vincent’s Hospital, Dublin, Ireland; 4. Morriston Hospital, Swansea, Wales, United Kingdom

Aims: The aim of this study was to provide contemporary outcome data for patients with de novo coronary disease and Medina 1,1,1 lesions who were treated with a

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bifurcationclinical researchradial
Read next article
Benefit of a new provisional stenting strategy, the re-proximal optimisation technique: the rePOT clinical study

Latest news